The ecotoxicity of methiocarb aqueous solutions treated by electrochemical oxidation was evaluated utilizing the model organism Daphnia magna. The electrodegradation experiments were performed using a boron-doped diamond anode and the influence of the applied current density and the supporting electrolyte (NaCl or Na2SO4) on methiocarb degradation and toxicity reduction were assessed. Electrooxidation treatment presented a remarkable efficiency in methiocarb complete degradation and a high potential for reducing the undesirable ecological effects of this priority substance. The reaction rate followed first-order kinetics in both electrolytes, being more favorable in a chloride medium. In fact, the presence of chloride increased the methiocarb removal rate and toxicity reduction and favored nitrogen removal. A 200× reduction in the acute toxicity towards D. magna, from 370.9 to 1.6 toxic units, was observed for the solutions prepared with NaCl after 5 h treatment at 100 A m−2. An increase in the applied current density led to an increase in toxicity towards D. magna of the treated solutions. At optimized experimental conditions, electrooxidation offers a suitable solution for the treatment and elimination of undesirable ecological effects of methiocarb contaminated industrial or agricultural wastewaters, ensuring that this highly hazardous pesticide is not transferred to the aquatic environment.
Burkholderia pseudomallei is a Gram-negative bacillus and the causative agent of melioidosis, a serious infection associated with high mortality rate in humans. It can be naturally found as an environmental saprophyte in soil or stagnant water, and rice paddies that predominate in regions of endemicity such as Northeast Thailand. B. pseudomallei is a Biosafety Level 3 organism due to risks of aerosolization and severe disease and is now included in formal emergency preparedness plans and guidelines issued by various authorities in the United States and Europe. Here, we report the first case of imported melioidosis in Portugal. B. pseudomallei was isolated from the patient's blood as well as from a left gluteal abscess pus. The isolate strain showed the unusual resistance profile to first-line eradication therapy trimethroprim/sulfamethoxazole. Whole genome sequencing revealed its similarity with isolates from Southeast Asia, suggesting the Thai origin of this Portuguese isolate, which is in agreement with a recent patient's travel to Thailand.
Thoracic aortic mural thrombi are rare in clinical practice, especially in non-aneurysmatic or nonatherosclerotic vessels. They are typically located in the descending aorta, and less frequently in the aortic arch, abdominal aorta, and ascending aorta. Although they are a rare cause of arterial embolization, this is their main manifestation. We present the case of a 48-year-old man, with no cardiovascular risk factors or history of trauma, who presented with acute arterial ischemia of the right upper limb. From the initial investigation, we highlight the presence of a pedunculated mass in the distal portion of the ascending aorta with signs of instability. Due to the risk of additional embolization, the patient was submitted to urgent surgery, with excision of the aortic defect, implantation of a tubular prosthesis as well as thromboembolectomy of the right brachial artery. The etiological evaluation of mural aortic thrombi is challenging and implies the exclusion of some prothrombotic conditions known to predispose to arterial thrombosis. This is a rare case that emphasizes the importance of considering the aorta as a possible source of peripheral embolization, even when there is no significant atherosclerotic or aneurysmatic disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.